APA (7th ed.) Citation

Li, G., Meng, G., Pan, G., Zhang, X., Yan, L., Li, R., . . . Li, T. (2023). MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway. Cancer Cell International, 23(1), 1. https://doi.org/10.1186/s12935-023-03034-1

Chicago Style (17th ed.) Citation

Li, Guang-Zhen, et al. "MALAT1/ Mir-1-3p Mediated BRF2 Expression Promotes HCC Progression via Inhibiting the LKB1/AMPK Signaling Pathway." Cancer Cell International 23, no. 1 (2023): 1. https://doi.org/10.1186/s12935-023-03034-1.

MLA (9th ed.) Citation

Li, Guang-Zhen, et al. "MALAT1/ Mir-1-3p Mediated BRF2 Expression Promotes HCC Progression via Inhibiting the LKB1/AMPK Signaling Pathway." Cancer Cell International, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12935-023-03034-1.